Table 1

Characteristics of the study population before and after surgery

VariablesTraining
(N=30)
Control
(N=31)
Age, years64.4±9.365.9±8.5
Female sex, n (%)17 (57)16 (52)
Body mass index, kg/m225.4±5.125.1±5.2
University degree or more, n39
Smoking history (pack-years)25.5 (0–87.5)20.0 (0–50.0)
Presence of COPD, n (%)10 (33)8 (26)
Thoracoscore1.64±1.262.19±1.83
Pneumonectomy, n (%)4 (13)6 (19)
Quality of life before surgery
 SF-36 score: Physical-component*48.3±9.048.3±11.9
 SF-36 score: Mental component*46.4±11.145.4±12.1
 EORTC QOL-C30: dyspnoea score†33.3 (0–100)33.3 (0–100)
Mean pulmonary function and cardiorespiratory fitness before surgery‡
 FEV1, % of predicted value88.6±20.791.7±23.5
 FVC, % of predicted value115.1±20.9111.6±22.9
 Tlco, % of predicted value81.4±18.183.9±24.2
 Peak oxygen uptake, mL/kg/min24.1±6.523.6±5.6
 Peak oxygen uptake, % of predicted value80.6±17.279.2±16.8
Histological features at surgery
 Adenocarcinoma, n (%)14 (47)16 (52)
 Squamous cell carcinoma, n (%)11 (37)10 (33)
 Large cell carcinoma, n (%)1 (3)0 (0)
 Other, n (%)4 (13)5 (15)
TNM stage[L2]
 Stage I, n (%)18 (60)15 (48)
 Stage II, n (%)7 (23)12 (39)
 Stage III, n (%)5 (17)5 (7)
 Stage IV, n (%)01 (3)
Additional treatment after surgery
 Chemotherapy, n (%)9 (30)9 (29)
 Radiotherapy, n (%)3 (10)4 (13)
  • Data are presented as mean±SD, median (range) or n (%).

  • *Higher scores indicate better functioning (scaled from 0–100).

  • †Lower scores indicate less dyspnoea (scaled from 0–100).

  • ‡Pulmonary function was calculated from equations from the European Community for Steel and Coal23 and peak oxygen uptake from the equations of Edvardsen and coworkers.24

  • COPD, chronic obstructive pulmonary disease defined as FEV1/FVC <70% and FEV1 <80% of predicted; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; MVV, maximal voluntary ventilation; Thoracoscore, the Thoracic Surgery Scoring System, which is a risk model for in-hospital events; Tlco, carbon monoxide transfer factor.